Vesa Cheng
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 15
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Jason A. Roberts (13 shared papers)Kiran Shekar (6 shared papers)Mohd H. Abdul‐Aziz (8 shared papers)Sam Rudham (4 shared papers)Claire Reynolds (4 shared papers)Hergen Buscher (4 shared papers)Amanda Corley (5 shared papers)Susan Welch (4 shared papers)
In The Last Decade
Vesa Cheng
18 papers receiving 240 citations
Peers
Comparison fields: 5 of 42
- Applied Microbiology and Biotechnology 19
- Pharmacology 123
- Critical Care and Intensive Care Medicine 27
- Molecular Medicine 28
- Anesthesiology and Pain Medicine 27
Countries citing papers authored by Vesa Cheng
This map shows the geographic impact of Vesa Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesa Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesa Cheng more than expected).
Fields of papers citing papers by Vesa Cheng
This network shows the impact of papers produced by Vesa Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesa Cheng. The network helps show where Vesa Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Vesa Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 118 | |
| 2 | 2015 | 24 | |
| 3 | 2018 | 22 | |
| 4 | 2021 | 19 | |
| 5 | 2022 | 13 | |
| 6 | Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study) | 2022 | 10 |
| 7 | 2018 | 9 | |
| 8 | 2019 | 7 | |
| 9 | 2022 | 6 | |
| 10 | 2024 | 4 | |
| 11 | 2019 | 2 | |
| 12 | 2024 | 2 | |
| 13 | Pharmacokinetics of Ceftriaxone During Prolonged Intermittent Renal Replacement Therapy in a Patient with Child–Pugh B Cirrhosis and Ascites | 2020 | 1 |
| 14 | 2020 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 0 |
About Vesa Cheng
Vesa Cheng is a scholar working on Pharmacology, Infectious Diseases, Molecular Medicine, Surgery and Anesthesiology and Pain Medicine, having authored 19 papers that have together received 242 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Antibiotic Resistance in Bacteria (3 papers), Antibiotic Use and Resistance (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Anesthesia and Sedative Agents (2 papers), Mechanical Circulatory Support Devices (2 papers) and Chronic Disease Management Strategies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Pharmacology (123 citations), Critical Care and Intensive Care Medicine (27 citations), Molecular Medicine (28 citations) and Anesthesiology and Pain Medicine (27 citations). Vesa Cheng has collaborated with scholars based in Australia, France and Hong Kong. Frequent co-authors include Jason A. Roberts, Kiran Shekar, Mohd H. Abdul‐Aziz, Sam Rudham, Claire Reynolds, Hergen Buscher, Amanda Corley, Susan Welch, Steven C. Wallis and Fay Burrows. Their work appears in journals such as Chemotherapy, Acta Anaesthesiologica Scandinavica, Journal of Interprofessional Care, Cochrane Database of Systematic Reviews and Current Infectious Disease Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.